Broad Institute brings CRISPR gene editing tool one step closer to human use
The MIT-Harvard team behind CRISPR-Cas9 gene-editing technology has found a way to use the tool in vivo, opening the way for therapeutic uses.
Archives for April 7, 2015
Infographic
Pfizer to be dominant biosimilar developer post Hospira deal
Pfizer will outpace the pack in terms of biosimilars in development once the $17bn acquisition of Hospira goes through.
Netherlands Medicines Evaluation Board says no ‘relevant differences’ between biosimilars, reference products
The Medicines Evaluation Board (MEB) of the Netherlands has updated its position about biosimilars, saying the relatively new products “have been proven to have no relevant differences compared to an innovator biological medicinal product as far as...